-
Categories
-
Healthcare & Medical
-
Expected Close Date
-
July 07, 2023
-
Target Raise
-
$100.00K-$250.00K
-
Security Price
-
$1
- Number of Employees
- 15
- Cash
- $3,115
- Revenue
- $2,000
- Short Term Debt
- $0
- Cost of Goods
- $0
- Long Term Debt
- $0
- Net Income
- $-9,385
Company Description
Heart disease is the number one killer of death, however it is 80% preventable through early screenings and interventions. Unfortunately, the majority of Americans face barriers to making it to in-person clinic visits, whether that’s due to logistical barriers like time, finding childcare, language, psychological barriers like trauma, or a pandemic. In fact, while Telemedicine rose 73X during the coronavirus pandemic, doctors are still unable to reach through a computer screen and listen to someone’s heart and lungs. As a result, life expectancy in the US hit a 20-year low, in large part due to the lack of preventative health screenings.
Key Deal Facts
The founder, Anna Li, is an MD PhD student at the University of Pittsburgh and Carnegie Mellon University with an interest in emergency medicine and computational biology., Korion Health was named one of the Top 10 Startups to Watch by the Pittsburgh Business Times, recently won first place in the John Hopkins Healthcare Innovation Challenge Digital Health Track, and has been featured in the New York Times for its revolutionary patient-centered approach to increasing access., Korion Health has been through five startup accelerators, including Blast Furnace, Ascender, LifeX, StartUp Shell, and StartOut, to round out their mentorship in business, health sciences, and tech., Korion Health already has a signed Letter of Intent (LOI) from a mid-size Telemedicine company for 50,000 of their electronic stethoscopes., SAFE investments, or Simple Agreement for Future Equity, are popular ways for early-stage companies to raise money. A SAFE investment issues to investors the right to certain shares of the company’s stock.